We are live on
!
Find out more
IAM
Innovis Asset Management Portfolio holdings
AUM
$260M
Turnover
30.65%
1-Year Est. Return
28.13%
This Fund
S&P 500
This Quarter
Est. Return
-2.3%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$260M
AUM Growth
-$11.2M
(-4.1%)
Cap. Flow
-$31.8K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
186
New
24
Increased
65
Reduced
40
Closed
33
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74M |
| 2 |
CrowdStrike
CRWD
|
+$3.61M |
| 3 |
Microsoft
MSFT
|
+$3.54M |
| 4 |
Boeing
BA
|
+$3.39M |
| 5 |
Tesla
TSLA
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$4.8M |
| 2 |
Starbucks
SBUX
|
+$4.25M |
| 3 |
Performance Food Group
PFGC
|
+$3.22M |
| 4 |
Coca-Cola
KO
|
+$2.59M |
| 5 |
Everpure Inc
P
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 20.01% |
| 3 | Financials | 9.68% |
| 4 | Energy | 8.3% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CANO
151
DELISTED
Cano Health, Inc.
CANO
| $80.7K | 0.03% |
3,181
-1,730
| -35% | -$142K |
2022 Q4
3 quarters
|
|
152
Evolv Technologies
EVLV
$757M
| $61.5K | 0.02% |
12,653
-12,367
| -49% | -$76.2K |
2022 Q4
3 quarters
|
|
153
PowerFleet Inc
AIOT
$334M
| $61.2K | 0.02% |
29,564
| – | – |
2023 Q1
2 quarters
|
|
154
Buckle
BKE
$2.4B
| – | – |
-9,863
| Closed | -$341K | – |
|
155
BRC Inc
BRCC
$150M
| – | – |
-2,270
| Closed | -$117K | – |
|
156
CDW
CDW
$19.3B
| – | – |
-1,350
| Closed | -$248K | – |
|
|
157
DexCom
DXCM
$33.1B
| – | – |
-37,345
| Closed | -$4.8M | – |
|
158
DELISTED
89bio
ETNB
| – | – |
-10,437
| Closed | -$198K | – |
|
159
Fortinet
FTNT
$133B
| – | – |
-4,875
| Closed | -$369K | – |
|
160
DELISTED
Generation Bio
GBIO
| – | – |
-1,002
| Closed | -$55.1K | – |
|
161
GE HealthCare
GEHC
$31.8B
| – | – |
-5,670
| Closed | -$461K | – |
|
162
Geron
GERN
$790M
| – | – |
-123,669
| Closed | -$397K | – |
|
163
DELISTED
Lazydays
GORV
| – | – |
-1,246
| Closed | -$432K | – |
|
164
Groupon
GRPN
$749M
| – | – |
-22,490
| Closed | -$133K | – |
|
165
Illumina
ILMN
$40.5B
| – | – |
-10,444
| Closed | -$1.9M | – |
|
166
Iovance Biotherapeutics
IOVA
$6.67B
| – | – |
-26,512
| Closed | -$187K | – |
|
|
167
Coca-Cola
KO
$396B
| – | – |
-43,074
| Closed | -$2.59M | – |
|
168
Nurix Therapeutics
NRIX
$2.73B
| – | – |
-15,648
| Closed | -$156K | – |
|
|
169
Performance Food Group
PFGC
$15.3B
| – | – |
-53,432
| Closed | -$3.22M | – |
|
170
Pliant Therapeutics
PLRX
$60.2M
| – | – |
-13,762
| Closed | -$249K | – |
|
171
Portillo's
PTLO
$347M
| – | – |
-9,522
| Closed | -$215K | – |
|
172
Peloton Interactive
PTON
$2.34B
| – | – |
-39,878
| Closed | -$307K | – |
|
173
PayPal
PYPL
$48.9B
| – | – |
-25,227
| Closed | -$1.68M | – |
|
|
174
Starbucks
SBUX
$110B
| – | – |
-42,861
| Closed | -$4.25M | – |
|
175
Schrodinger
SDGR
$1.91B
| – | – |
-5,316
| Closed | -$265K | – |
|
Similar funds
RCGI
RBGI
AEPLI
PWM
T
SC
CA
W
Innovis Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Innovis Asset Management held 186 positions worth $260M, down 4.1% from $271M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Innovis Asset Management's Q3 2023 filing shows 24 new, 65 increased, 40 reduced and 33 closed positions. Its largest new stake was Boeing: 15,478 shares worth $2.97M. The largest sale was DexCom, an estimated $4.8M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Innovis Asset Management's largest Q3 2023 buy was Boeing: 15,478 shares worth $2.97M.
- Innovis Asset Management added most to Amazon in Q3 2023, an estimated $3.74M increase.
- Innovis Asset Management's biggest Q3 2023 reduction was Everpure Inc, cutting an estimated $2.58M.
- Innovis Asset Management fully exited DexCom in Q3 2023, selling an estimated $4.8M.
- Innovis Asset Management's ten largest holdings make up 35% of its $260M portfolio in Q3 2023.
- Innovis Asset Management opened 24 new positions and closed 33 in Q3 2023.
- Innovis Asset Management's portfolio value fell 4.1% quarter-over-quarter to $260M.
Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.